summary
Introduced
09/19/2019
09/19/2019
In Committee
09/20/2019
09/20/2019
Crossed Over
Passed
Dead
12/31/2020
12/31/2020
Introduced Session
116th Congress
Bill Summary
Requires the Department of Health and Human Services (HHS) to maintain a website and undertake other activities to educate health care providers, patients, and caregivers about biological products, biosimilar biological products, and interchangeable biosimilar biological products. Among other activities, HHS must develop or improve continuing education programs that address clinical considerations for biological and related products. Health care providers eligible for the Merit-based Incentive Payment System in Medicare may count completion of such a program as a clinical practice improvement activity.
AI Summary
This bill requires the Department of Health and Human Services (HHS) to maintain a website and undertake other activities to educate healthcare providers, patients, and caregivers about biological products, biosimilar biological products, and interchangeable biosimilar biological products. The bill also allows healthcare providers eligible for the Merit-based Incentive Payment System (MIPS) in Medicare to count the completion of a continuing education program on these topics as a clinical practice improvement activity, earning them one-half of the highest potential score for that performance category.
Committee Categories
Business and Industry, Health and Social Services
Sponsors (2)
Last Action
Referred to the Subcommittee on Health. (on 09/20/2019)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/116th-congress/house-bill/4400/all-info |
| BillText | https://www.congress.gov/116/bills/hr4400/BILLS-116hr4400ih.pdf |
| Bill | https://www.congress.gov/116/bills/hr4400/BILLS-116hr4400ih.pdf.pdf |
Loading...